All In MedTech

Device Trial Radar · NCT06717789

Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain

Post-Market Prospective Clinical Follow Up Study on the Symptomatic Treatment of Musculoskeletal Pain Through Sensory Nerve Stimulation Using the Compex SP8.0 Device

Last checked: Nov 20, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

74

Actual

Start

Apr 1, 2025

Primary completion

Dec 31, 2025

Study completion Dec 31, 2025

Sponsor

Lead sponsor
DJO UK LtdNot on our public-company list
Sponsor type
Industry
First posted
Dec 5, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post-market clinical study of the SP8.0 Compex device aims to comprehensively assess the safety and performance of the device when used in accordance with the approved Instructions for Use. The results of this study will also support the clinical evaluation of the next-generation wireless product currently under development. The Compex Consumer devices contain different programs, such as conditioning, fitness, recovery, massage, rehabilitation, and pain management. This study will utilize the Compex SP 8.0 pain management programs, with the aim of assessing the effectiveness of the treatment provided by the device in managing pain through different physiological mechanisms.

Conditions

  • Musculoskeletal Conditions
  • Musculoskeletal Pain

Interventions

  • Transcutaneous Electrical Nerve Stimulation (TENS) with the Compex SP8.0 deviceDevice

    Transcutaneous Electrical Nerve Stimulation (TENS) with the Compex SP8.0 device, using the following pain management program, • High Intensity TENS (50-150 Hz)

  • Transcutaneous Electrical Nerve Stimulation (TENS) with the Compex SP8.0 deviceDevice

    Transcutaneous Electrical Nerve Stimulation (TENS) with the Compex SP8.0 device, using the following pain management program, • Low Intensity TENS (5 Hz)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in pain levelTime frame: From enrollment to full recovery or end of treatment at week 4

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Salford University Sports Injury Clinic

    Salford, Manchester, United Kingdom

  • Worsley Physiotherapy and Sports Injuries Clinic

    Worsley, Manchester, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.